Keywords
Statin
Muscle strength
Frailty
Older adult
Categories
How to Cite
Abstract
Introduction: Heart failure is a chronic disease associated with different cardiovascular diseases. The management of this disease is based on the control of cardiovascular risk factors, in some cases, using different drugs, such as statins in the treatment of dyslipidemia. However, there are not enough studies evaluating the influence of statin use on muscle strength. Since frail elderly people may be more vulnerable to the side effects of statins, it would be of interest to evaluate the possible association between the use of statins and loss of muscle strength in patients with heart failure. Patients and Methods: We conducted an observational retrospective study including patients from the PROFUND-IC registry, which studied pluripathological patients hospitalized for acute heart failure. We described the different characteristics between statin users and non-users and compared handgrip strength between both groups. Results: A total of 476 patients were included, of whom 53.2% (253) had a median age of 84 years and were on statin therapy. Handgrip strength was pathological in 81% of statin users compared to 84.7% of non-users. Multivariate analysis showed no differences in handgrip strength between statin users and non-users, with an overall OR value of 1.036 (p = 0.94). Conclusion: Our study does not show an association between the use of statins and worse handgrip strength in older patients with heart failure. Therefore, frailty or older age should not be a limitation for the prescription of statins.
References
Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016 Jun;13(6):368-78. doi: 10.1038/nrcardio.2016.25. Epub 2016 Mar 3. PMID: 26935038; PMCID: PMC4868779
Niazi M, Galehdar N, Jamshidi M, Mohammadi R, Moayyedkazemi A. A Review of the Role of Statins in Heart Failure Treatment. Curr Clin Pharmacol. 2020; 15(1):30-37. doi:10.2174/1574884714666190802125627
Costa S, Reina-Couto M, Albino-Teixeira A, Sousa T. Statins and oxidative stress in chronic heart failure. Rev Port Cardiol. 2016;35(1):41-57. doi:10.1016/j.repc.2015.09.006
Greig D, Alcaino H, Castro PF, et al. Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters. J Heart Lung Transplant. 2011;30(4):408-413. doi:10.1016/j.healun.2010.10.003
Andreou I, Tousoulis D, Miliou A, et al. Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study. Atherosclerosis. 2010;210(1):194-198. doi:10.1016/j.atherosclerosis.2009.10.046
Javaheri A, Rader DJ, Javaheri S. Statin therapy in heart failure. Is it time for a second look? Hypertension. (2014)63:909–10. doi: 10.1161/HYPERTENSIONAHA.113.02703
Gouveia R, Madureira S, Elias C, et al. Lower low density lipoprotein cholesterol associates to higher mortality in non-diabetic heart failure patients. Int J Cardiol Cardiovasc Risk Prev. 2023; 18:200197. Published 2023 Jul 16. doi:10.1016/j.ijcrp.2023.200197
Bielecka-Dabrowa A, Fabis J, Mikhailidis DP, et al. Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure. Trends Pharmacol Sci. 2018; 39(4):331-353. doi:10.1016/j.tips.2018.02.003
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbac A, Böhm M, et al. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol. 2022; 75(6):523.e1–523.e11. DOI: 10.1016/j.recesp.2021.11.027.
Ahmad F, Karim A, Khan J, Qaisar R. Statin Therapy Induces Gut Leakage and Neuromuscular Disjunction in Patients With Chronic Heart Failure. J Cardiovasc Pharmacol. 2023;82(3):189-195. Published 2023 Sep 1. doi:10.1097/FJC.0000000000001445
Valdiviesso R, Sousa-Santos AR, Azevedo LF, et al. Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study. BMC Cardiovasc Disord. 2022; 22(1):356. doi:10.1186/s12872-022-02804-5
Mallery LH, Moorhouse P, McLean Veysey P, Allen M, Fleming I. Severely frail elderly patients do not need lipid-lowering drugs. Cleve Clin J Med. 2017; 84(2):131-142. doi:10.3949/ccjm.84a.15114
Agostini JV, Tinetti ME, Han L, McAvay G, Foody JM, Concato J. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc. 2007; 55(3):420-425. doi:10.1111/j.1532-5415.2007.01071.x
Yorke AM, Curtis AB, Shoemaker M, Vangsnes E. Grip strength values stratified by age, gender, and chronic disease status in adults aged 50 years and older. J Geriatr Phys Ther. 2015; 38(3):115-121. doi:10.1519/JPT.0000000000000037.
Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V, Galizia G, Della-Morte D, Gargiulo G, Cacciatore F, Bonaduce D, Landi F, Abete P. Sarcopenia and Heart Failure. Nutrients. 2020 Jan 14;12(1):211. doi: 10.3390/nu12010211. PMID: 31947528; PMCID: PMC7019352
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19; 388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8. Erratum in: Lancet. 2017 Feb 11; 389(10069):602. PMID: 27616593)
Chillarón JJ, Benaiges D, Climent E, Flores-Le Roux JA, PedroBotet J. Statins and heart failure. J Cardiol Ther. (2015)2:405–9. doi: 10.17554/j.issn.2309-6861.2015.02.86
Lee MMY, Sattar N, McMurray JJV, Packard CJ. Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence. Curr Atheroscler Rep. 2019 Jul 27; 21(10):41. doi: 10.1007/s11883-019-0800-z. PMID: 31350612; PMCID: PMC666050)
Kjekshus J, Apetrei E, Barrios V, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007; 357(22):2248-2261. doi:10.1056/NEJMoa0706201
Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372(9645):1223-1230. doi:10.1016/S0140-6736(08)61239-8
Packer M. Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medications. Eur J Heart Fail. 2018 Jul; 20(7):1100-1105. doi: 10.1002/ejhf.1183. Epub 2018 Mar 22. PMID: 29566300)
Techorueangwiwat, C., Kanitsoraphan, C., Hansrivijit, P. (2021). Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature. F1000Research, 10, 16. https://doi.org/10.12688/f1000research.28254.1
Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009; 102(9):625-633. doi:10.1093/qjmed/hcp093.
Golomb BA, Evans MA, Dimsdale JE, White HL. Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Arch Intern Med. 2012; 172(15):1180-1182. doi:10.1001/archinternmed.2012.2171
Witham MD, Syddall HE, Dennison E, Cooper C, McMurdo ME, Sayer AA. ACE inhibitors, statins and thiazides: no association with change in grip strength among community dwelling older men and women from the Hertfordshire Cohort Study. Age Ageing. 2014 Sep;43(5):661-6. doi: 10.1093/ageing/afu008. Epub 2014 Feb 11. PMID: 24522120
Alturki M, Liberman K, Delaere A, et al. Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training. Drugs Aging. 2021;38(3):253-263. doi:10.1007/s40266-020-00831-5
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Lucia Gandía-Blanquer, Paula Hernández-Sanjuán, Rebeca Fuerte-Martínez, Gonzalo Serralta-San Martin, Jorge Francisco Gómez-Cerezo, Fernando Aguilar-Rodríguez, Manuel Méndez-Bailón, Llanos Soler-Rangel